Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$57.1M |
| 2 |
Veralto
VLTO
|
+$54.6M |
| 3 |
Newmont
NEM
|
+$40.4M |
| 4 |
Vertiv
VRT
|
+$17.2M |
| 5 |
Webster Financial
WBS
|
+$14.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$314M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$237M |
| 3 |
Microsoft
MSFT
|
+$231M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.88% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.38% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
PureCycle Technologies
PCT
$1.44B
| $851K | ﹤0.01% |
210,100
+12,200
| +6% | +$53.6K |
|
|
CTLP
2327
DELISTED
Cantaloupe
CTLP
| $849K | ﹤0.01% |
114,600
-12,900
| -10% | -$89.1K |
|
2328
SoundHound AI
SOUN
$3.29B
| $849K | ﹤0.01% |
400,500
+49,000
| +14% | +$97.1K |
|
|
FFIC
2329
DELISTED
Flushing Financial
FFIC
| $847K | ﹤0.01% |
51,423
-7,000
| -12% | -$97.6K |
|
2330
Tarsus Pharmaceuticals
TARS
$3.07B
| $847K | ﹤0.01% |
41,833
-7,600
| -15% | -$127K |
|
|
CVAC
2331
DELISTED
CureVac
CVAC
| $846K | ﹤0.01% |
198,547
-22,859
| -10% | -$124K |
|
2332
Mission Produce
AVO
$1.13B
| $846K | ﹤0.01% |
83,800
-9,500
| -10% | -$88.3K |
|
2333
Cellebrite
CLBT
$3.8B
| $845K | ﹤0.01% |
97,600
-10,200
| -9% | -$79.3K |
|
2334
National Presto Industries
NPK
$998M
| $843K | ﹤0.01% |
10,500
-1,100
| -9% | -$84.5K |
|
2335
4D Molecular Therapeutics
FDMT
$621M
| $841K | ﹤0.01% |
41,500
-4,600
| -10% | -$60.5K |
|
2336
ATN International
ATNI
$478M
| $838K | ﹤0.01% |
21,500
-2,700
| -11% | -$89.2K |
|
|
SPWR
2337
DELISTED
SunPower Corporation Common Stock
SPWR
| $834K | ﹤0.01% |
172,600
-19,700
| -10% | -$94K |
|
2338
Daily Journal
DJCO
$767M
| $832K | ﹤0.01% |
+2,442
| New | +$764K |
|
2339
Vital Farms
VITL
$495M
| $830K | ﹤0.01% |
52,900
-9,200
| -15% | -$116K |
|
2340
Tiptree Inc
TIPT
$668M
| $825K | ﹤0.01% |
43,523
-5,000
| -10% | -$86.5K |
|
2341
Bally's
BALY
$671M
| $816K | ﹤0.01% |
58,525
-7,500
| -11% | -$84.2K |
|
2342
MaxCyte
MXCT
$136M
| $815K | ﹤0.01% |
173,500
-16,900
| -9% | -$65.8K |
|
2343
Sinclair Inc
SBGI
$1B
| $815K | ﹤0.01% |
62,550
-6,500
| -9% | -$79.8K |
|
2344
Ituran Location and Control
ITRN
$1.07B
| $812K | ﹤0.01% |
29,825
-3,500
| -11% | -$92.5K |
|
2345
TTEC Holdings
TTEC
$77.4M
| $810K | ﹤0.01% |
37,400
-3,800
| -9% | -$80K |
|
|
FNA
2346
DELISTED
Paragon 28, Inc.
FNA
| $809K | ﹤0.01% |
65,100
-6,600
| -9% | -$69.8K |
|
|
CDMO
2347
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $809K | ﹤0.01% |
124,400
-13,500
| -10% | -$87K |
|
|
TGB
2348
Trekor Metals
TGB
$3.2B
| $804K | ﹤0.01% |
572,000
-51,700
| -8% | -$63.5K |
|
2349
Vishay Precision Group
VPG
$934M
| $804K | ﹤0.01% |
23,600
-2,400
| -9% | -$75.2K |
|
2350
Arhaus
ARHS
$1.37B
| $803K | ﹤0.01% |
67,800
-6,800
| -9% | -$64.1K |
|
Similar funds
Swiss National Bank's Q4 2023 Portfolio in Review
As of Q4 2023, Swiss National Bank held 2,646 positions worth $136B, up 6.9% from $127B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank withdrew a net $4.96B in Q4 2023, closing 112 positions and reducing 2,341 holdings. Its most notable exit was Activision Blizzard, an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Veralto worth $60.2M.
- Swiss National Bank's largest Q4 2023 buy was Veralto: 731,669 shares worth $60.2M.
- Swiss National Bank added most to Broadcom in Q4 2023, an estimated $57.1M increase.
- Swiss National Bank's biggest Q4 2023 reduction was Apple, cutting an estimated $314M.
- Swiss National Bank fully exited Activision Blizzard in Q4 2023, selling an estimated $237M.
- Swiss National Bank's ten largest holdings make up 28% of its $136B portfolio in Q4 2023.
- Swiss National Bank opened 38 new positions and closed 112 in Q4 2023.
- Swiss National Bank's portfolio value rose 6.9% quarter-over-quarter to $136B.
Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.